The Fansided NHL Network, that SenShot is proud to be a member of, is embarking on its NHL preview. Each day in September, one of its members will be posting a preview for their club. SenShot will look at their preview, and let you have a look. After that, we will provide our own perspective. Jared will handle the Western Conference teams while Tony will look at the East.
Today, we’ll preview the Atlantic division’s New York Rangers.
Follow Blue Line Station‘s lead writer, Adam Herman on Twitter here for all your Ranger’s news and info.
Here’s SenShot’s take on the upcoming Ranger’s season:
The Rangers are going for it all this season. With the Rangers winning the bidding war for Brad Richards services this off-season, they hope that they have found their answer down the middle that will take their team to the next level.
With their offense ranked 16th last season, Richards should be able to help in that department and push them into the top ten in the league. With his 49 assists last season in a injury plagued year, if he can stay healthy, Richards could be able to turn Marion Gaborik into a 50 goal scorer.
On the back-end, the Rangers have a good young core that are entering their prime as Marc Staal and Dan Girardi lead the D-unit. In goal, Henrik Lundqvist is one of the best in the league and will again be a Vezina candidate.
The Rangers have the pieces to make an impact this year. As long as no major injuries affect their core, the Rangers have an opportunity to take advantage as some of the powerhouses in the East have taken a step back. I wouldn’t want to play the Rangers in the first round of the playoffs.
**Don’t forget to buy your Tickets for SenShot’s Alfie Night in Ottawa on November 11th, 2011. Click here for more details**
Thanks for reading and as always, comments are welcomed.
Can’t get enough of SenShot? Here are more ways to get the most info about your Ottawa Senators.
Visit our SenShot Facebook Page. Like us and post comments, photos and videos.
Please visit our NHL Main Page: Too Many Men On The Site.